These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10078023)

  • 21. Ribavirin in the treatment of hepatitis C.
    Abonyi ME; Lakatos PL
    Anticancer Res; 2005; 25(2B):1315-20. PubMed ID: 15865084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of hepatitis C virus genotype 4.
    Abdo AA; Lee SS
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1233-9. PubMed ID: 15482528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HCV research and anti-HCV drug discovery: toward the next generation.
    Wakita T
    Adv Drug Deliv Rev; 2007 Oct; 59(12):1196-9. PubMed ID: 17905463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical evaluation of positive- and negative-stranded HCV-RNAs in liver in relation to IFN therapy].
    Hino K; Murakami C; Fujii K; Okazaki M; Okuda M; Hanada H; Okita K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):949-53. PubMed ID: 7563907
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
    Edamoto Y; Tani M; Kurata T; Abe K
    Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
    Chu CM; Sheen IS; Liaw YF
    Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.
    Lehmann M; Meyer MF; Monazahian M; Tillmann HL; Manns MP; Wedemeyer H
    J Med Virol; 2004 Jul; 73(3):387-91. PubMed ID: 15170633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [HCV-RNA in liver of chronic hepatitis C--plus strand RNA and minus strand RNA].
    Endo H; Yamada G
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):623-8. PubMed ID: 7563844
    [No Abstract]   [Full Text] [Related]  

  • 29. [HCV-RNA of the hepatocytes of the complete responders with disappearance serum HCV-RNA after IFN treatment--using in situ hybridization].
    Terada M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):944-8. PubMed ID: 7563906
    [No Abstract]   [Full Text] [Related]  

  • 30. [Detection of hepatitis C virus RNA].
    Ohishi W; Chayama K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):214-8. PubMed ID: 15359795
    [No Abstract]   [Full Text] [Related]  

  • 31. Future studies of combination therapy for chronic hepatitis C: optimizing response rates for each hepatitis C population.
    Main J
    J Hepatol; 1995; 23 Suppl 2():32-5; discussion 35-6. PubMed ID: 8720292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transient reappearance of serum hepatitis C virus RNA observed by real-time PCR during antiviral therapy with peginterferon and ribavirin: Reappearance of references published in 2005-2009.
    Gelderblom HC; Beld MG
    J Clin Virol; 2010 Jun; 48(2):150-1; author reply 152. PubMed ID: 20347385
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatitis C in childhood.
    Sibal A; Mishra D; Arora M
    J Indian Med Assoc; 2002 Feb; 100(2):93-8. PubMed ID: 12206357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [HCV-RNA quantity of the serum].
    Sasaki Y; Hige S; Nagasaka A; Matsushima T
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):965-8. PubMed ID: 7563911
    [No Abstract]   [Full Text] [Related]  

  • 35. [HLA and hepatitis C virus positive cardiomyopathy].
    Naruse TK; Inoko H
    Nihon Rinsho; 2000 Jan; 58(1):212-7. PubMed ID: 10885316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of hepatitis C virus in cardiomyopathies.
    Matsumori A
    Ernst Schering Res Found Workshop; 2006; (55):99-120. PubMed ID: 16329660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus from the hearts of patients with myocarditis and cardiomyopathy.
    Matsumori A; Yutani C; Ikeda Y; Kawai S; Sasayama S
    Lab Invest; 2000 Jul; 80(7):1137-42. PubMed ID: 10908160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of hepatitis C virus RNA in the hearts of patients with hepatogenic cardiomyopathy.
    Takeda A; Sakata A; Takeda N
    Mol Cell Biochem; 1999 May; 195(1-2):257-61. PubMed ID: 10395090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symposium on clinical aspects in hepatitis virus infection. 5. Clinical practice of hepatitis: myocardial diseases, nephritis, and vasculitis associated with hepatitis virus.
    Matsumori A
    Intern Med; 2001 Feb; 40(2):182-4. PubMed ID: 11300163
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular surveillance of hepatitis C.
    Khudyakov Y
    Antivir Ther; 2012; 17(7 Pt B):1465-70. PubMed ID: 23321496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.